| Model Number |
VEDR01 |
| Medical Device Problem Code |
Pacing Problem (1439)
|
| Health Effect - Clinical Code |
Bradycardia (1751)
|
| Date of Event |
01/03/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Continuation of d10: fr995-21 tissue valve implanted on (b)(6) 2008 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient experienced bradycardia.The implantable pulse generator (ipg) was pacing below programmed settings.The ipg was explanted due to elective replacement indicator (eri) and replaced. no further patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Product event summary: the device was returned and analyzed.Analysis of the device revealed normal battery depletion.The device was returned due to device pacing below programmed settings after 124.6 months.The device was received in a no telemetry no output condition.The device loss of telemetry and all functions were due to a severely depleted battery.The device was fully functional and operated under normal current drain when powered with an external supply.Pacing resumed when powered with an external power supply.There was no evidence of a high current drain condition, and no hybrid anomalies were observed.It was determined that the device met specifications for normal operation and normal battery depletion.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|